Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jun;20(6):732-9.
doi: 10.1007/s00467-004-1805-5. Epub 2005 Mar 22.

Dysregulation of renal MMP-3 and MMP-7 in canine X-linked Alport syndrome

Affiliations

Dysregulation of renal MMP-3 and MMP-7 in canine X-linked Alport syndrome

Velidi H Rao et al. Pediatr Nephrol. 2005 Jun.

Abstract

Matrix metalloproteinases (MMPs) play an important regulatory role in many biological and pathological processes and their specific role in Alport syndrome (AS) is not yet clearly defined. In this study, the naturally occurring canine X-linked AS was used to demonstrate a potential role for MMP-3 and MMP-7 in Alport renal pathogenesis. Recently, we demonstrated that the expression of MMP-2, MMP-9 and MMP-14 was upregulated in the renal cortex of dogs with a spontaneous form of XLAS. In the present study, we examined necropsy samples of renal cortex from normal and XLAS dogs for MMP-3 and MMP-7 as they have the potential to activate MMP-2 and MMP-9. Immunohistochemical analysis showed strong immunostaining for both MMP-3 and MMP-7 in the interstitial space of XLAS kidneys, while virtually no immunostaining was observed in similar fields from normal dogs. RT-PCR and casein zymography confirmed that both mRNA transcripts and activities of MMP-3 and MMP-7 are elevated in XLAS kidneys. The induction of these MMPs likely contributes to tissue destruction associated with the fibrogenic process, while augmenting the activation of MMP-2 and MMP-9 by MMP-3 and MMP-7 in XLAS. Thus, these data further implicate a role for the MMPs in progressive renal pathogenesis associated with AS.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1997 May 15;99(10):2470-8 - PubMed
    1. Kidney Int. 2003 Apr;63(4):1338-55 - PubMed
    1. Biol Chem Hoppe Seyler. 1995 Jun;376(6):345-55 - PubMed
    1. Medicine (Baltimore). 1999 Sep;78(5):338-60 - PubMed
    1. Biochem Biophys Res Commun. 1994 Oct 28;204(2):613-20 - PubMed

Publication types

Substances

LinkOut - more resources